Published in Eur J Immunol on April 01, 1994
Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc Natl Acad Sci U S A (2001) 0.89
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med (1995) 3.67
DNA-based immunization by in vivo transfection of dendritic cells. Nat Med (1996) 3.62
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med (1996) 2.69
Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl Acad Sci U S A (1992) 2.56
Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol (2001) 1.95
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol (1992) 1.91
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol (2000) 1.60
TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med (1986) 1.49
Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood (2001) 1.47
TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor. Cell (1988) 1.36
Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol (1998) 1.31
The LY-6 locus: a multigene family encoding phosphatidylinositol-anchored membrane proteins concerned with T-cell activation. Immunol Rev (1989) 1.31
Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. J Immunol (1994) 1.23
Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proc Natl Acad Sci U S A (1998) 1.22
Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18
Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol (1996) 1.17
Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J Immunol (1992) 1.16
Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J Immunol (1998) 1.16
Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med (1996) 1.15
Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus. J Immunol (1987) 1.14
CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci U S A (1999) 1.14
Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J Immunol (2000) 1.12
Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest (1995) 1.11
The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J Immunol (1998) 1.09
Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol (2001) 1.08
Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. Hum Gene Ther (2000) 1.08
T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP. J Immunol (1988) 1.06
Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation. J Immunol (1989) 1.04
Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc Natl Acad Sci U S A (1993) 1.03
The expression, function, and ontogeny of a novel T cell-activating protein, TAP, in the thymus. J Immunol (1986) 1.03
Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity. J Invest Dermatol (1997) 1.02
Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus. Proc Natl Acad Sci U S A (1986) 1.01
IL-4: role in disease and regulation of production. Clin Exp Immunol (1998) 1.00
Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes. Proc Natl Acad Sci U S A (1985) 0.98
A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology (1999) 0.96
Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes. Proc Natl Acad Sci U S A (1986) 0.96
Treatment of pyogenic granulomas with the 585 nm pulsed dye laser. J Am Acad Dermatol (1996) 0.95
Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen. Eur J Immunol (1993) 0.95
la-positive T lymphocytes are the producer cells of interferon gamma. Exp Cell Res (1984) 0.93
Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. Mol Ther (2001) 0.92
Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases. Proc Natl Acad Sci U S A (1987) 0.92
DNA immunization targeting the skin: molecular control of adaptive immunity. J Invest Dermatol (1998) 0.91
Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo. J Gene Med (2001) 0.90
Direct transfection and activation of human cutaneous dendritic cells. Gene Ther (2001) 0.90
Activation of CD4+ T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules. Proc Natl Acad Sci U S A (1996) 0.86
Enhanced murine CD4+ T cell responses induced by the CD2 ligand CD48. Eur J Immunol (1998) 0.85
Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor. Immunol Res (1998) 0.84
The sgp-60 molecule is linked to the plasma membrane via a glycosylphosphatidylinositol anchor. Eur J Immunol (1991) 0.84
'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity. Gene Ther (2005) 0.83
Analysis of mast cells in rheumatoid arthritis and osteoarthritis by an avidin-peroxidase staining. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 0.83
Retinal oxygen consumption in vitro. The effect of diabetes mellitus, oxygen and glucose. Acta Ophthalmol (Copenh) (1990) 0.82
Distribution of lysozyme in synovial tissue of patients with osteoarthritis and rheumatoid arthritis demonstrated by different enzyme histochemical methods. Rheumatol Int (1982) 0.82
Identification, by protein sequencing and gene transfection, of sgp-60 as the murine homologue of CD48. Proc Natl Acad Sci U S A (1993) 0.82
Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene. Genes Immun (2005) 0.82
Transcriptional IL-15-directed in vivo DC targeting DNA vaccine. Gene Ther (2009) 0.81
Expression of T-cell-activating protein in peripheral lymphocyte subsets. Proc Natl Acad Sci U S A (1986) 0.81
Avidin-peroxidase. A new mast cell staining method. Acta Histochem Suppl (1986) 0.80
Biosynthesis, glycosylation, and partial N-terminal amino acid sequence of the T-cell-activating protein TAP. Proc Natl Acad Sci U S A (1987) 0.80
Modulation of the intracellular Ca2+ and inositol trisphosphate concentrations in murine T lymphocytes by the glycosylphosphatidylinositol-anchored protein sgp-60. J Immunol (1993) 0.80
Novel approach to gene expression profiling in Sézary syndrome. Br J Dermatol (2010) 0.79
The murine Cd48 gene: allelic polymorphism in the IgV-like region. Eur J Immunogenet (1998) 0.76
Giving DNA vaccines a helping hand. Nat Med (1998) 0.75
Control of Hemorrhage from Wounds of the Coronary Vessels by the Gelatin Sponge Patch Technic: An Experimental Study. Ann Surg (1949) 0.75
T cell-activating protein on murine lymphocytes. Fed Proc (1986) 0.75
Distribution of mast cells in human synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Z Rheumatol (1985) 0.75
[7-fluoro-4-chromone-3-sulfur compounds]. Arch Pharm (Weinheim) (1994) 0.75
Cytotoxic T cells in basal cell carcinomas of skin. Am J Dermatopathol (1998) 0.75
[3 new antibody detection tests. A comparative study]. Beitr Infusionsther (1990) 0.75
The immunology of DNA vaccines. Methods Mol Med (2000) 0.75
[The GOX-anti-GOX(PAP) technic, a new method for the demonstration of adjacent antigens in the same section]. Acta Histochem Suppl (1985) 0.75
[Iodine deficiency--clinical consequences and possibilities for prevention]. Med Welt (1983) 0.75
Effects of in vivo monoclonal anti-I-A antibody treatment in neonatal mice on intrathymic and peripheral class II antigen expression. Cell Immunol (1988) 0.75
Generating and regulating immune responses through cutaneous gene delivery. Hum Gene Ther (2000) 0.75